Cargando…

Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits

BACKGROUND: Many organizations have suggested a minimum standard regarding pharmaceutical counselling for patients, which includes information about the name of the drug, the description the drug, the indication for use, how to use it, the method of treatment, precautions, adverse reactions, and any...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Qarni, Hassan, Alrahbini, Tahani, AlQarni, Ayidh M, Alqarni, Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425153/
https://www.ncbi.nlm.nih.gov/pubmed/32791962
http://dx.doi.org/10.1186/s12913-020-05554-2
_version_ 1783570442866393088
author Al Qarni, Hassan
Alrahbini, Tahani
AlQarni, Ayidh M
Alqarni, Abdullah
author_facet Al Qarni, Hassan
Alrahbini, Tahani
AlQarni, Ayidh M
Alqarni, Abdullah
author_sort Al Qarni, Hassan
collection PubMed
description BACKGROUND: Many organizations have suggested a minimum standard regarding pharmaceutical counselling for patients, which includes information about the name of the drug, the description the drug, the indication for use, how to use it, the method of treatment, precautions, adverse reactions, and any contraindications. Correspondingly, the World Health Organization (WHO) has recommended that pharmacists spend at least 3 min with each patient to provide counselling. This study aimed to evaluate the counselling practices of community pharmacists for both over-the-counter (OTC) and prescription-only medicines in the Bisha Health Directorate, Saudi Arabia. METHOD: This was a cross-sectional study designed to evaluate simulated patient visits to observe real counselling practices of community pharmacies in the Bisha area; 73 pharmacies were visited. Two scenarios were used in this study. The first scenario was for a prescription-only medicine, and the second scenario was for an OTC medicine. The duration of counselling was recorded for every visit. RESULTS: A total of 105 visits to the 73 pharmacies were conducted under the following scenarios: scenario 1 = 73 visits and scenario 2 = 32 visits. The average time for the simulation was 110 s for scenario 1 and 73.4 s for scenario 2. There was a statistically significant negative correlation between the duration of counselling and patient simulation visits that occurred in the morning (Spearman’s rho = − 0.396, p = 0.001). CONCLUSION: It was shown that patient counselling needs to be given greater emphasis in community pharmacies. In this study, the time spent for patient counselling failed to meet the minimum WHO standard. Thus, pharmacists must be encouraged to spend at least 3 min on patient counselling.
format Online
Article
Text
id pubmed-7425153
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74251532020-08-16 Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits Al Qarni, Hassan Alrahbini, Tahani AlQarni, Ayidh M Alqarni, Abdullah BMC Health Serv Res Research Article BACKGROUND: Many organizations have suggested a minimum standard regarding pharmaceutical counselling for patients, which includes information about the name of the drug, the description the drug, the indication for use, how to use it, the method of treatment, precautions, adverse reactions, and any contraindications. Correspondingly, the World Health Organization (WHO) has recommended that pharmacists spend at least 3 min with each patient to provide counselling. This study aimed to evaluate the counselling practices of community pharmacists for both over-the-counter (OTC) and prescription-only medicines in the Bisha Health Directorate, Saudi Arabia. METHOD: This was a cross-sectional study designed to evaluate simulated patient visits to observe real counselling practices of community pharmacies in the Bisha area; 73 pharmacies were visited. Two scenarios were used in this study. The first scenario was for a prescription-only medicine, and the second scenario was for an OTC medicine. The duration of counselling was recorded for every visit. RESULTS: A total of 105 visits to the 73 pharmacies were conducted under the following scenarios: scenario 1 = 73 visits and scenario 2 = 32 visits. The average time for the simulation was 110 s for scenario 1 and 73.4 s for scenario 2. There was a statistically significant negative correlation between the duration of counselling and patient simulation visits that occurred in the morning (Spearman’s rho = − 0.396, p = 0.001). CONCLUSION: It was shown that patient counselling needs to be given greater emphasis in community pharmacies. In this study, the time spent for patient counselling failed to meet the minimum WHO standard. Thus, pharmacists must be encouraged to spend at least 3 min on patient counselling. BioMed Central 2020-08-13 /pmc/articles/PMC7425153/ /pubmed/32791962 http://dx.doi.org/10.1186/s12913-020-05554-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Al Qarni, Hassan
Alrahbini, Tahani
AlQarni, Ayidh M
Alqarni, Abdullah
Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits
title Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits
title_full Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits
title_fullStr Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits
title_full_unstemmed Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits
title_short Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia –simulated patient visits
title_sort community pharmacist counselling practices in the bisha health directorate, saudi arabia –simulated patient visits
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425153/
https://www.ncbi.nlm.nih.gov/pubmed/32791962
http://dx.doi.org/10.1186/s12913-020-05554-2
work_keys_str_mv AT alqarnihassan communitypharmacistcounsellingpracticesinthebishahealthdirectoratesaudiarabiasimulatedpatientvisits
AT alrahbinitahani communitypharmacistcounsellingpracticesinthebishahealthdirectoratesaudiarabiasimulatedpatientvisits
AT alqarniayidhm communitypharmacistcounsellingpracticesinthebishahealthdirectoratesaudiarabiasimulatedpatientvisits
AT alqarniabdullah communitypharmacistcounsellingpracticesinthebishahealthdirectoratesaudiarabiasimulatedpatientvisits